Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan

Autor: Christopher Wen, Jack A. Roth, Shuanbei Wu, Sonia A. Cunningham, Maosheng Huang, Chi Pang Wen, Xifeng Wu, Jian Gu, Chwen Keng Tsao, Wong Ho Chow, Min Kwang Tsai, Xia Pu, Yuanqing Ye, Chad D. Huff, Scott M. Lippman
Rok vydání: 2016
Předmět:
Male
Lung Neoplasms
National Health Programs
Cohort Studies
0302 clinical medicine
Carcinoembryonic antigen
Risk Factors
030212 general & internal medicine
Prospective Studies
Family history
Prospective cohort study
Lung
Tomography
Cancer
education.field_of_study
Multidisciplinary
Smokers
biology
Lung Cancer
Discriminant Analysis
Middle Aged
X-Ray Computed
Respiratory Function Tests
C-Reactive Protein
030220 oncology & carcinogenesis
Area Under Curve
Female
alpha-Fetoproteins
Risk assessment
Cohort study
medicine.medical_specialty
Population
Taiwan
Risk Assessment
Article
03 medical and health sciences
Clinical Research
Internal medicine
Tobacco
medicine
Humans
education
Lung cancer
Author Correction
Aged
Proportional Hazards Models
Tobacco Smoke and Health
business.industry
Prevention
Retrospective cohort study
Bilirubin
medicine.disease
respiratory tract diseases
Carcinoembryonic Antigen
Good Health and Well Being
ROC Curve
Multivariate Analysis
Physical therapy
biology.protein
business
Tomography
X-Ray Computed
Zdroj: Scientific Reports
Scientific reports, vol 6, iss 1
ISSN: 2045-2322
Popis: The objective of this study was to develop markedly improved risk prediction models for lung cancer using a prospective cohort of 395,875 participants in Taiwan. Discriminatory accuracy was measured by generation of receiver operator curves and estimation of area under the curve (AUC). In multivariate Cox regression analysis, age, gender, smoking pack-years, family history of lung cancer, personal cancer history, BMI, lung function test, and serum biomarkers such as carcinoembryonic antigen (CEA), bilirubin, alpha fetoprotein (AFP), and c-reactive protein (CRP) were identified and included in an integrative risk prediction model. The AUC in overall population was 0.851 (95% CI = 0.840–0.862), with never smokers 0.806 (95% CI = 0.790–0.819), light smokers 0.847 (95% CI = 0.824–0.871), and heavy smokers 0.732 (95% CI = 0.708–0.752). By integrating risk factors such as family history of lung cancer, CEA and AFP for light smokers, and lung function test (Maximum Mid-Expiratory Flow, MMEF25–75%), AFP and CEA for never smokers, light and never smokers with cancer risks as high as those within heavy smokers could be identified. The risk model for heavy smokers can allow us to stratify heavy smokers into subgroups with distinct risks, which, if applied to low-dose computed tomography (LDCT) screening, may greatly reduce false positives.
Databáze: OpenAIRE